Global Lithotripsy Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Lithotripsy Devices Market Size

• The global lithotripsy devices market size was valued at USD 2.49 billion in 2025 and is expected to reach USD 4.18 billion by 2033, at a CAGR of 6.70% during the forecast period
• The market growth is largely fueled by the increasing prevalence of kidney stone disorders and rising demand for minimally invasive treatment options, which are safer and more efficient than traditional surgery. Technological advancements in lithotripsy systems and expanding healthcare infrastructure are also supporting uptake globally
• Furthermore, growing awareness of non‑surgical treatment alternatives, higher healthcare expenditure, and broader adoption of advanced urological solutions in both hospital and outpatient settings are driving sustained demand. These converging factors are accelerating the uptake of lithotripsy devices, thereby significantly boosting the industry’s growth

Lithotripsy Devices Market Analysis

• Lithotripsy devices, which use shock wave or laser technology to non-invasively break kidney stones, are increasingly critical components of modern urological treatment in both hospital and outpatient settings due to their efficiency, safety, and reduced recovery times
• The escalating demand for lithotripsy devices is primarily fueled by the rising prevalence of kidney stone disorders, increasing awareness of minimally invasive treatment options, and the growing preference for non-surgical solutions that reduce patient discomfort and hospital stay
• North America dominated the lithotripsy devices market with the largest revenue share of 39.7% in 2025, driven by advanced healthcare infrastructure, high healthcare expenditure, and strong presence of key industry players. The U.S. witnessed substantial adoption of advanced shock wave and laser lithotripsy systems in hospitals and specialty clinics, supported by continuous technological innovations from both established medical device companies and startups
• Asia-Pacific is expected to be the fastest-growing region in the lithotripsy devices market during the forecast period due to increasing healthcare access, rising incidence of kidney stone disorders, and expanding investment in modern urological treatment facilities
• Extracorporeal Shock Wave Lithotripsy (ESWL) segment dominated the market with a market share of 44.2% in 2025, driven by its non-invasive nature, proven clinical efficacy, and ease of integration into existing urology departments

Report Scope and Lithotripsy Devices Market Segmentation 

Lithotripsy Devices Market Trends

“Advancements in Laser and Shock Wave Technologies”

• A significant and accelerating trend in the global lithotripsy devices market is the continuous enhancement of shock wave and laser lithotripsy systems, improving treatment precision, reducing procedure times, and minimizing patient discomfort
• For instance, the Dornier Delta III laser lithotripsy system offers advanced pulse modulation for efficient stone fragmentation with minimal tissue damage, while new mobile extracorporeal shock wave lithotripters enable outpatient procedures
• Integration of real-time imaging and AI-assisted targeting in lithotripsy devices enables more precise stone localization and personalized treatment plans, reducing retreatment rates and improving clinical outcomes
• The seamless combination of minimally invasive technology with user-friendly operation interfaces allows urologists to perform procedures more efficiently, optimize workflow, and provide better patient care in both hospital and clinic settings
• This trend toward smarter, more precise, and less invasive lithotripsy devices is fundamentally transforming expectations for urological treatment, encouraging manufacturers such as Olympus to develop AI-assisted laser lithotripters with automated stone detection and optimized energy delivery
• The demand for lithotripsy devices that offer high precision, reduced side effects, and faster recovery times is growing rapidly across both developed and emerging markets, as healthcare providers increasingly prioritize patient safety and operational efficiency
• Rising research in dual-modality devices combining laser and shock wave technology is creating opportunities for multi-functional systems that improve treatment versatility and clinical outcomes

Lithotripsy Devices Market Dynamics

Driver

“Increasing Prevalence of Kidney Stone Disorders and Demand for Minimally Invasive Treatments”

• The rising incidence of kidney stone disorders worldwide, coupled with the growing preference for minimally invasive treatment options, is a significant driver of heightened demand for lithotripsy devices
• For instance, in March 2025, Storz Medical launched an upgraded electromagnetic lithotripter designed for outpatient and hospital settings, targeting improved stone fragmentation efficiency and patient comfort
• As patients and clinicians seek safer and less invasive alternatives to surgical procedures, lithotripsy devices offer high success rates, reduced hospitalization, and minimal recovery times compared to traditional surgery
• Furthermore, increasing healthcare investments, expansion of specialized urology centers, and wider availability of advanced lithotripsy systems in emerging economies are facilitating broader adoption
• The convenience of outpatient procedures, faster recovery, and the ability to treat multiple stone types with single devices are key factors propelling the adoption of lithotripsy systems globally
• Rising awareness campaigns about kidney stone prevention and treatment in high-risk populations are encouraging earlier diagnosis and adoption of lithotripsy devices
• Collaborations between device manufacturers and healthcare providers to offer training programs and clinical support are helping hospitals integrate advanced lithotripsy technologies more effectively

Restraint/Challenge

“High Device Cost and Regulatory Compliance Hurdles”

• The relatively high initial cost of advanced lithotripsy devices, including laser and mobile shock wave systems, poses a significant challenge to broader market penetration, particularly in price-sensitive regions
• For instance, procurement costs and ongoing maintenance expenses for high-end lithotripters in small clinics can limit adoption despite clinical benefits
• Stringent regulatory approvals and compliance requirements for medical devices across different regions increase time-to-market and add complexity for manufacturers seeking global distribution
• While prices of portable and compact lithotripters are gradually decreasing, the perceived premium for cutting-edge technology can hinder adoption among smaller healthcare providers, especially in developing markets
• Overcoming these challenges through cost optimization, regulatory support, and demonstrating long-term clinical and economic benefits will be vital for sustained market growth and wider adoption of lithotripsy solutions
• Limited availability of trained personnel to operate advanced lithotripsy systems in smaller hospitals or remote regions can restrict market penetration
• Variations in reimbursement policies and healthcare coverage across countries can impact the affordability and accessibility of lithotripsy treatments, creating adoption barrier

Lithotripsy Devices Market Scope

The market is segmented on the basis of type, modality, application, and end user.

• By Type

On the basis of type, the lithotripsy devices market is segmented into intracorporeal lithotripsy and extracorporeal shock wave lithotripsy (ESWL). The ESWL segment dominated the market with the largest revenue share of 44.2% in 2025, driven by its non-invasive approach and proven clinical efficacy in treating kidney stones. ESWL devices are widely used in hospitals and specialty clinics due to their ability to fragment stones without surgery, reducing patient recovery time and hospital stay. The segment benefits from technological advancements such as portable and high-frequency shock wave systems that increase treatment precision and patient comfort. ESWL is also preferred for outpatient procedures, making it accessible to a broader patient base. Healthcare providers value ESWL for its efficiency in treating multiple stone types and its reduced risk of complications compared to traditional surgical procedures. In addition, strong clinician familiarity and long-standing clinical evidence support sustained adoption globally.

The intracorporeal lithotripsy segment is expected to witness the fastest growth at a CAGR of approximately 6.9% from 2026 to 2033, fueled by rising adoption of laser-based devices for ureteral, pancreatic, and bile duct stones. Intracorporeal systems, including holmium laser lithotripters, offer high precision, flexibility in endoscopic procedures, and the ability to reach difficult stone locations. The growing preference for minimally invasive procedures and the increasing number of urology procedures in emerging markets are driving this growth. Surgeons benefit from the device’s compact design, real-time imaging integration, and improved energy delivery for effective stone fragmentation. Furthermore, patient awareness of less invasive treatment options is increasing demand for intracorporeal lithotripsy in outpatient and ambulatory settings.

• By Modality

On the basis of modality, the market is segmented into standalone and portable lithotripsy devices. The standalone segment dominated the market with the largest revenue share in 2025 due to its high capacity, robust performance, and suitability for hospital and specialty clinic environments. Standalone devices are often equipped with advanced imaging and shock wave technologies, enabling accurate targeting of stones and high treatment efficacy. Hospitals prefer standalone systems for high patient throughput and the ability to manage a wide range of stone sizes and locations. The segment benefits from clinician familiarity, reliability, and strong manufacturer support in terms of training and maintenance. Large hospitals and urology centers favor standalone devices due to their integration with existing hospital workflows and comprehensive safety features. Their durability and capability to handle complex cases reinforce their dominance in the lithotripsy market.

The portable segment is expected to witness the fastest growth from 2026 to 2033, driven by increasing demand in outpatient facilities, smaller clinics, and rural healthcare centers. Portable lithotripsy systems offer mobility, lower operational costs, and simplified setup, making treatment more accessible outside major hospitals. The devices are particularly advantageous in emerging markets with limited access to large hospital infrastructure. Innovations in battery-powered and compact shock wave devices are further accelerating adoption. The portability factor allows healthcare providers to serve remote populations, increasing overall market penetration.

• By Application

On the basis of application, the market is segmented into kidney stones, ureteral stones, bile duct stones, and pancreatic stones. The kidney stone segment dominated the market with the largest revenue share in 2025, as kidney stones are the most prevalent urolithiasis condition globally. The segment is supported by rising incidence rates, increasing awareness of minimally invasive treatments, and strong adoption of ESWL and laser lithotripsy systems in hospitals. Clinicians prefer lithotripsy for kidney stones due to high success rates, lower complications, and reduced hospitalization. Technological advancements in energy delivery and real-time imaging further enhance treatment outcomes. The growing patient pool and demand for outpatient treatment contribute to sustained dominance. Effective clinical results, combined with rising healthcare expenditure in developed countries, reinforce this segment’s market leadership.

The ureteral stones segment is expected to witness the fastest growth from 2026 to 2033 due to increasing use of intracorporeal laser lithotripsy for stones located in narrow ureter passages. The segment benefits from technological innovations that allow flexible endoscopic access, precise stone fragmentation, and reduced risk of ureteral injury. Rising prevalence of ureteral calculi and increasing adoption of minimally invasive urology procedures are driving this growth. Patients increasingly prefer outpatient treatments that reduce discomfort and recovery time. Moreover, improved insurance coverage and hospital infrastructure in emerging economies are expanding access to these procedures.

• By End User

On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment dominated the market with the largest revenue share in 2025 due to the presence of advanced urology departments, high patient volumes, and preference for high-capacity lithotripsy devices. Hospitals benefit from integrated imaging systems, trained personnel, and support services for maintenance and device training. Large hospitals and specialty urology centers invest in both ESWL and intracorporeal devices to provide comprehensive treatment options for kidney, ureteral, and bile duct stones. The segment is driven by robust healthcare infrastructure, insurance coverage, and increasing demand for minimally invasive procedures. Hospitals also benefit from continuous technological upgrades that enhance procedural efficiency and patient safety.

The ambulatory surgical centers segment is expected to witness the fastest growth from 2026 to 2033 due to increasing demand for outpatient treatment, cost-effective procedures, and shorter recovery times. Portable lithotripsy devices, compact imaging systems, and user-friendly operation interfaces are facilitating adoption in these centers. The growth is further fueled by rising patient preference for outpatient treatments and expanding private healthcare infrastructure. Ambulatory centers can offer flexible scheduling, lower costs, and personalized care, which makes them increasingly attractive for kidney stone management. Rising awareness of minimally invasive treatments among patients and healthcare providers is accelerating this trend globally.

Lithotripsy Devices Market Regional Analysis

• North America dominated the lithotripsy devices market with the largest revenue share of 39.7% in 2025, driven by advanced healthcare infrastructure, high healthcare expenditure, and strong presence of key industry players
• Healthcare providers in the region highly value the precision, efficiency, and patient safety offered by advanced lithotripsy devices, including both ESWL and intracorporeal systems, for treating kidney, ureteral, and bile duct stones
• This widespread adoption is further supported by high healthcare expenditure, well-trained urology specialists, and strong presence of key medical device manufacturers, establishing lithotripsy devices as the preferred solution for hospitals and specialty clinics across the U.S. and Canada

U.S. Lithotripsy Devices Market Insight

The U.S. lithotripsy devices market captured the largest revenue share of 79% in North America in 2025, fueled by the widespread adoption of minimally invasive urological procedures and advanced healthcare infrastructure. Hospitals and specialty clinics are increasingly prioritizing the use of ESWL and laser-based lithotripsy systems to treat kidney, ureteral, and bile duct stones efficiently. The growing focus on outpatient treatment, patient safety, and faster recovery times is further propelling the market. Moreover, continuous technological innovations, integration of real-time imaging, and AI-assisted targeting in devices are significantly contributing to market expansion. Rising awareness of kidney stone prevention and early treatment among patients is also encouraging adoption.

Europe Lithotripsy Devices Market Insight

The Europe lithotripsy devices market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by high prevalence of kidney and ureteral stones and growing preference for minimally invasive treatment options. Strong healthcare infrastructure, government support for advanced urological care, and well-developed insurance coverage are fostering adoption. European hospitals and clinics are increasingly integrating shock wave and laser lithotripsy systems into both new and existing urology departments. Rising awareness of non-surgical treatments, combined with patient demand for outpatient procedures, is further boosting market growth. Countries such as France, Italy, and Spain are witnessing consistent investments in modern urology centers.

U.K. Lithotripsy Devices Market Insight

The U.K. lithotripsy devices market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by rising incidence of kidney stone disorders and the increasing focus on minimally invasive urological care. Hospitals and specialty clinics are adopting advanced laser lithotripters and ESWL systems to improve patient outcomes and reduce hospital stays. Concerns regarding procedural complications and patient comfort are encouraging healthcare providers to implement modern lithotripsy solutions. The U.K.’s well-established healthcare infrastructure and strong adoption of outpatient procedures are expected to continue stimulating market growth. Growing awareness campaigns on kidney stone treatment and prevention are also supporting adoption in both public and private hospitals.

Germany Lithotripsy Devices Market Insight

The Germany lithotripsy devices market is expected to expand at a considerable CAGR during the forecast period, fueled by increasing awareness of non-invasive urology treatments and rising healthcare investments. Germany’s technologically advanced hospital infrastructure, high patient awareness, and emphasis on medical innovation promote the adoption of both ESWL and laser lithotripsy systems. The integration of imaging systems with lithotripsy devices enhances treatment precision and safety, aligning with local regulatory standards. Strong reimbursement coverage and preference for outpatient care further support market growth. Adoption is increasing in both residential clinics and large hospitals specializing in urology.

Asia-Pacific Lithotripsy Devices Market Insight

The Asia-Pacific lithotripsy devices market is poised to grow at the fastest CAGR of ~8% from 2026 to 2033, driven by increasing prevalence of kidney stone disorders, expanding healthcare infrastructure, and rising disposable incomes in countries such as China, Japan, and India. Growing awareness of minimally invasive treatments, increasing number of outpatient clinics, and government initiatives supporting urology care are accelerating adoption. Technological advancements in portable and compact lithotripsy devices are enhancing accessibility in remote areas. The region’s focus on affordable treatment options and expanding private healthcare sector are key factors driving growth. Rising urbanization and increasing patient awareness of treatment options are further boosting market penetration.

Japan Lithotripsy Devices Market Insight

The Japan lithotripsy devices market is gaining momentum due to the country’s high-tech medical environment, advanced healthcare facilities, and rising incidence of kidney and ureteral stones. Hospitals are increasingly integrating laser and shock wave lithotripsy systems with imaging and AI-assisted targeting for enhanced procedural precision. The aging population and preference for minimally invasive treatments are driving demand for outpatient procedures. Integration of devices with hospital management systems improves efficiency and patient monitoring. The focus on patient safety, rapid recovery, and reduced hospitalization further fuels adoption. Rising awareness campaigns and health insurance coverage for non-surgical procedures are also supporting market expansion.

India Lithotripsy Devices Market Insight

The India lithotripsy devices market accounted for the largest market revenue share in Asia-Pacific in 2025, attributed to rapid urbanization, growing prevalence of kidney stone disorders, and expanding healthcare infrastructure. Hospitals and ambulatory surgical centers are adopting both ESWL and laser-based devices to meet increasing patient demand for minimally invasive procedures. Government initiatives supporting healthcare modernization, along with strong domestic manufacturing of medical devices, are propelling market growth. Affordable treatment options, increasing private hospital investments, and rising patient awareness about non-surgical alternatives are key factors driving adoption. India’s focus on outpatient and cost-effective procedures further enhances market potential.

Lithotripsy Devices Market Share

The Lithotripsy Devices industry is primarily led by well-established companies, including:

• Boston Scientific Corporation (U.S.)
• E.M.S. Electro Medical Systems S.A. (Switzerland)
• Cook (U.S.)
• Olympus Corporation (Japan)
• Richard Wolf GmbH (Germany)
• DirexGroup (Germany)
• Novamedtek LLC (Turkey)
• Walz Elektronik GmbH (Germany)
• Lumenis Ltd. (Israel)
• Medispec Ltd. (Israel)
• Elmed Medical Systems (Turkey)
• Karl Storz SE & Co. KG (Germany)
• Allengers Medical Systems Ltd. (India)
• Convergent Laser Technologies (U.S.)
• Medtronic plc (Ireland)
• Technomed Systems Pvt. Ltd. (India)
• NOVAmedtek LLC (Turkey)
• EMS Electro Medical Systems (Switzerland)
• Siemens Healthineers AG (Germany)
• Dornier MedTech (Germany)

What are the Recent Developments in Global Lithotripsy Devices Market?

• In January 2026, SonoMotion received FDA 510(k) clearance for the Break Wave lithotripsy device, a non‑invasive, anesthesia‑free ultrasound‑based system designed to fragment kidney stones with real‑time imaging guidance, representing a major regulatory milestone for emerging lithotripsy technology
• In October 2025, Avvio Medical received FDA Breakthrough Device Designation for its Enhanced Lithotripsy System (ELS), supporting faster review pathways and expert FDA collaboration for a next‑generation ureteral stone treatment expected to expand access to minimally invasive care
• In September 2025, Johnson & Johnson announced the European launch of the Shockwave Javelin Peripheral IVL Catheter, making the novel lithotripsy‑based device available in Europe to modify calcified occlusions and broaden treatment options for patients with peripheral artery disease
• In May 2025, Avvio Medical announced the first patients treated using its Enhanced Lithotripsy System (ELS) a novel microbubble‑enhanced acoustic cavitation technology intended to improve kidney stone treatment in outpatient and office settings without general anesthesia, marking a key clinical advancement in lithotripsy
• In March 2025, Shockwave Medical launched the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter in the U.S., introducing a first‑of‑its‑kind forward IVL platform designed to treat calcified lesions in peripheral artery disease representing a significant expansion of lithotripsy‑derived technology beyond urinary stone

SKU-22010